Journal of Thrombosis and Haemostasis
Publisher: Elsevier · ISSN 1538-7836 · 95 articles
- “Being stung by the Taipan: high rates of false positivity for lupus anticoagulant using Taipan snake venom time in patients on warfarin with a low probability of antiphospholipid syndrome”: reply
- “Monitoring unfractionated heparin: time to move beyond the activated partial thromboplastin time”: comment
- “Monitoring unfractionated heparin: time to move beyond the activated partial thromboplastin time”: reply
- “Use of factor concentrates for the management of perioperative bleeding: guidance from the ISTH SSC subcommittee on perioperative and critical care thrombosis and hemostasis”: comment
- “Use of factor concentrates for the management of perioperative bleeding: guidance from the ISTH SSC Subcommittee on Perioperative and Critical Care Thrombosis and Hemostasis”: reply
- The natural mutation Arg221aTrp in human α-thrombin abrogates physiological Na+ binding and preferentially hinders the protease anticoagulant functions
- SrcE97A Mediates convergent regulation of arterial/venous thrombosis and immune homeostasis via β3–Src dissociation
- Predicting deep venous thrombosis and pulmonary embolism in community patients with superficial venous thrombosis: a model development study
- Direct oral anticoagulant use and drug–drug interactions in transplant recipients receiving calcineurin inhibitors
- Explaining recurrent thrombotic events and predicting bleeding in critically ill neonates diagnosed with umbilical central venous catheter-related portal vein thrombosis
- Suspicion-based screening for occult malignancy in lower-extremity venous thrombosis: a real-world cohort study
- Association of fibrinogen γ’ with recurrent thrombosis: a nested case-control study
- Carbon tetrachloride (CCl4)-induced liver injury activates hepatocyte-independent tissue factor-driven coagulation
- Plasma levels of adiponectin and risk of future incident venous thromboembolism
- TQB3473, a novel spleen tyrosine kinase inhibitor for primary immune thrombocytopenia: a single-arm, open-label, multicenter phase 1 study
- RNA sequencing indicates distinct platelet transcriptomic changes in immune thrombocytopenia
- Immunogenic risk assessment of porcine, bovine, and ovine heparins for diversifying the global heparin supply
- Rab31 promotes platelet activation and arterial thrombosis via ERK–PLCβ3 signaling and regulation of CD151
- A historical review of the biological, semantic and clinical aspects of aspirin resistance
- Major Bleeding After Catheter-Directed Thrombolysis for Acute Pulmonary Embolism: Derivation and Transferability of the F-HARP Risk Assessment Model
- A standardised ultrasound strategy safely excludes recurrent deep-vein thrombosis without prior imaging.
- Comparative analysis of genes encoding hemostatic proteins in human acute promyelocytic leukemia cells and acute myeloid leukemia cells and their murine counterparts
- Internal lysis of contracted clots is accelerated by fiber alignment and bundling
- Disseminated intravascular coagulopathy in pregnancy: lessons from an international registry of the International Society for Thrombosis and Hemostasis: communication from the SSC of the ISTH
- Joint effect of muscle strength and physical inactivity on risk of incident venous thromboembolism: the Tromsø Study
- Diagnostic utility of the von Willebrand factor collagen-binding activity assay in patients with mild-to-moderate bleeding: results from the Vienna Bleeding Biobank
- Thrombotic rates in individuals with inherited bleeding disorders treated with concentrate or bispecific antibody. Fifteen-year EUHASS data
- KRAS mutation and venous thromboembolism risk in colorectal cancer: a Danish population-based cohort study
- Fragility analysis should complement statistical reporting in thrombosis trials: lessons from reduced-dose direct oral anticoagulants for cancer-associated venous thromboembolism
- Coactivators YAP and TAZ contribute differently to the transcriptional regulation of VWF in endothelial cells